SymbolBLCO
NameBAUSCH + LOMB CORPORATION COMMON SHARES
SectorUNDEFINED
RegionUNDEFINED
IndustryOphthalmic Goods
Address520 APPLEWOOD CRESCENT, VAUGHAN, Ontario, L4K 4B4, Canada
Telephone+1 905 695-7700
Fax
Email
Website
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001860742
Description

Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a public company once again in May 2022. The firm reports in three segments-vision care and consumer (60% of revenue), surgical (20%), and ophthalmic pharmaceuticals (20%). The company is geographically diversified, with 48% of revenue in the Americas, 30% from EMEA, and 22% from Asia-Pacific countries.

Additional info from NASDAQ:
Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a public company once again in May 2022. The firm reports in three segments-vision care and consumer (60% of revenue), surgical (20%), and ophthalmic pharmaceuticals (20%). The company is geographically diversified, with 48% of revenue in the Americas, 30% from EMEA, and 22% from Asia-Pacific countries.

2026-09-11 10:11

Bausch + Lomb Announces European CE Mark Approval of SeeLyra™ Femtosecond Laser

Read more
2026-09-02 11:00

Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience

Read more
2026-09-01 10:58

Most Women Don't Recognize Dry Eye as a Symptom of Perimenopause and Menopause, New Bausch + Lomb Survey Finds

Read more
2026-08-24 20:30

Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results

Read more
2026-08-14 21:47

Director Trebbi Barbara 🟢 acquired 11.8K shares of Bausch & Lomb Corp (BLCO) Transaction Date: Aug 12, 2026 | Filing ID: 000105

Read more
2026-08-14 21:34

Director PAUL LAURENCE E 🟢 acquired 11.8K shares of Bausch & Lomb Corp (BLCO) Transaction Date: Aug 12, 2026 | Filing ID: 000102

Read more
2026-08-14 21:25

Director Chersi Robert J 🟢 acquired 11.8K shares of Bausch & Lomb Corp (BLCO) Transaction Date: Aug 12, 2026 | Filing ID: 000100

Read more
2026-08-14 18:45

New Form 3 - Bausch & Lomb Corp <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001860742-26-000104 <b>Size:</b> 6 KB

Read more
2026-08-14 18:34

New Form 3 - Bausch & Lomb Corp <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001860742-26-000101 <b>Size:</b> 6 KB

Read more
2026-08-14 18:23

New Form 3 - Bausch & Lomb Corp <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001860742-26-000099 <b>Size:</b> 6 KB

Read more